Document is current
Any future updates will be listed below
-
Authors
Loffredo, Lucas F.
Kustagi, Anmol
Ringham, Olivia R.
Li, Fangda
de los Santos-Alexis, Kenia
Saqi, Anjali https://orcid.org/0000-0003-3133-9886
Arpaia, Nicholas https://orcid.org/0000-0002-0657-0528
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R21AI149657)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL148718)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA013696)
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 20 February 2025
First Online: 3 March 2025
Competing interests
: A.S. reports grants or contracts from Boehringer Ingelheim and Genentech to institution, consulting fees from Genentech, Gilead, Abbvie, and Veracyte, payment or honoraria from Medscape, Physician’s Education Resource, Memorial Sloan Kettering, Bronx Lebanon, and New York University, support for attending meeting or traveling from International Association for Study of Lung Cancer, College of American Pathologists, patents of Device for cell blocks and Major Pathological Calculator Tool, and stocks of Link Biosystems. The other authors claim no competing interests.
